Top

Category: Biotech


Biotech, Industry

Yumanity’s days as an independent biotech come to a close

June 6, 2022

Via: Biopharma Dive

After nearly eight years, Yumanity’s time as an independent company appears close to an end. The biotech was established in late 2014 — the creation of Tony Coles, Susan Lindquist and Ken Rhodes, each well-known in the pharmaceutical industry for […]


Biotech, Industry

Biotech Athersys to lay off 70% of staff in cost-cutting effort

June 6, 2022

Via: Biopharma Dive

Athersys’s research efforts are centered around a cell therapy platform it has been studying across a range of conditions, including stroke, respiratory distress and heart attack. In stroke, Athersys is working with Japan’s Healios, which tested Athersys’ cell therapy as […]


Biotech, Industry

A cash-strapped biotech winds down operations

May 25, 2022

Via: Biopharma Dive

Established in 2006, Genocea originally focused on vaccines. It went public in 2014 and at one point saw its shares soar above $150. But in 2017, just as the company was poised to begin a Phase 3 trial of an […]


Biotech, Industry

When will biotech markets get better? BridgeBio fears they may stay ‘pretty bad’ until 2024

May 24, 2022

Via: FierceBiotech

BridgeBio Pharma is digging in for a prolonged bear market. Since suffering a phase 3 flop late last year, the biotech has taken a series of steps to extend its cash runway, reflecting its CEO’s belief that markets could “stay […]


Biotech, Industry

Innoviva buys struggling antibiotic biotech Entasis, as the AstraZeneca spin out preps FDA filing

May 23, 2022

Via: FierceBiotech

Holding company Innoviva is acquiring late-stage antibiotic biotech Entasis Therapeutics, a 2015 AstraZeneca spin-out that just posted phase 3 results worthy of an FDA filing last year. Innoviva already owns about 60% of Entasis’ outstanding shares. Under the new definitive […]


Biotech, Industry

Trial setback casts doubt on a biotech’s respiratory virus drug

May 19, 2022

Via: Biopharma Dive

A common infection, RSV results in only mild, cold-like symptoms in most people. Yet the disease causes 58,000 hospitalizations a year in children under 5 and 177,000 in the elderly. After decades of disappointment, vaccine makers may finally be close […]


Biotech, Industry

ALSA Ventures, Lonza Partner to Provide Biotech Support & Services

May 9, 2022

Via: Contract Pharma

ALSA Ventures, a London based European biotech investment firm, and Lonza, a global development and manufacturing partner to the pharma, biotech and nutrition industries, have entered a collaboration agreement to help develop and manufacture biologics and small molecule drug candidates […]


Biotech, Industry

Big pharma resisting temptation for biotech M&A spree until prices drop further

May 5, 2022

Via: FierceBiotech

Plunging valuations may be forcing biotechs to lay off staff and strip back their pipelines, but Big Pharma doesn’t think the price tags on offer are sufficiently tempting to justify a shopping trip quite yet. Judging by first-quarter earnings calls […]


Biotech, Industry

AstraZeneca and Daiichi set to broaden use of breast cancer drug, challenging Roche

May 5, 2022

Via: Biopharma Dive

The approval of Enhertu as a second-line option further establishes the drug’s growing role in breast cancer, where it’s quickly becoming a go-to treatment for the roughly 15% of patients with HER2-positive disease. First conditionally approved for third-line use in […]


Biotech, Industry

Record-breaking 2021 revenue shows there’s more to Swiss biotech sector than Roche, Novartis

May 4, 2022

Via: FierceBiotech

Swiss biotechs saw record-breaking revenue and R&D investment in 2021, which the industry hopes will lead people to look beyond homegrown giants like Roche and Novartis. The new findings, outlined by the Swiss Biotech Association in its latest annual report […]


Biotech, Industry

Emerging Plant-based Platform for Biomanufacturing

May 2, 2022

Via: Biopharm International

In the midst of new emerging therapy projects under development, the progress of innovative manufacturing technologies is also growing. One of the newest emerging platforms for biologics manufacturing is the plant made pharmaceutical platform (PMP). PMP has come on-stage recently […]


Biotech, Industry

How a surprise finding made an Alnylam study one of biotech’s most ‘polarizing’ trials

April 25, 2022

Via: Biopharma Dive

The results didn’t add up. BridgeBio Pharma, a young biotech trying to bring its first big drug to market, followed the blueprint of one of the world’s largest pharmaceutical companies. It made a medicine meant to work like the one […]